Betalin Therapeutics

About:

Betalin Therapeutics develops a cell therapy solution for insulin-dependent diabetes, an Engineered Micro-Pancreas (EMP).

Website: http://www.betalintherapeutics.com/

Top Investors: European Innovation Council, EASME - EU Executive Agency for SMEs

Description:

Betalin Therapeutics is a privately-held company. We develop a cell therapy solution for insulin-dependent diabetes, an Engineered Micro-Pancreas (EMP). The EMP is a combination of harvested pancreatic islets (also known as Islets of Langerhans) and a proprietary biological micro-environment for supporting the harvested cells. After promising in-vitro results and preliminary in-vivo results, Betalin Therapeutics is currently putting efforts to further optimize the therapy in animal models, complete submission of the Investigational New Drug (IND) application to the FDA, and proceed to clinical trials.